Seth J. Welsh

523 total citations
10 papers, 135 citations indexed

About

Seth J. Welsh is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Seth J. Welsh has authored 10 papers receiving a total of 135 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 5 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in Seth J. Welsh's work include Multiple Myeloma Research and Treatments (6 papers), Protein Degradation and Inhibitors (5 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Seth J. Welsh is often cited by papers focused on Multiple Myeloma Research and Treatments (6 papers), Protein Degradation and Inhibitors (5 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Seth J. Welsh collaborates with scholars based in United States, Canada and India. Seth J. Welsh's co-authors include Erin W. Meermeier, P. Leif Bergsagel, Meaghen E. Sharik, Daniel L. Riggs, Victoria M. Garbitt, Marta Chesi, Caleb K. Stein, Chang‐Xin Shi, Bryant Chau and Matthew L. Wheeler and has published in prestigious journals such as Blood, Cancer Research and Leukemia.

In The Last Decade

Seth J. Welsh

9 papers receiving 135 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Seth J. Welsh United States	4	63	59	52	42	42	10	135
Anetta Marcinek Germany	4	36 0.6×	74 1.3×	74 1.4×	28 0.7×	29 0.7×	16	122
Bettina Brauchle Germany	4	29 0.5×	71 1.2×	62 1.2×	25 0.6×	30 0.7×	12	107
Martina Sersch China	7	25 0.4×	154 2.6×	29 0.6×	73 1.7×	16 0.4×	13	182
Donna Roscoe United States	4	19 0.3×	82 1.4×	28 0.5×	42 1.0×	36 0.9×	4	149
Caleb K. Stein United States	5	62 1.0×	67 1.1×	32 0.6×	55 1.3×	41 1.0×	9	128
Sungwoo Ahn Canada	7	59 0.9×	61 1.0×	23 0.4×	43 1.0×	29 0.7×	17	98
Kenichi Ishiyama Japan	7	25 0.4×	44 0.7×	51 1.0×	45 1.1×	8 0.2×	12	125
Eleanor Berrie United Kingdom	3	54 0.9×	33 0.6×	59 1.1×	20 0.5×	21 0.5×	4	108
Luzalba Sanoja-Flores Spain	6	55 0.9×	47 0.8×	38 0.7×	65 1.5×	5 0.1×	12	131
Idoia Rodríguez Spain	2	106 1.7×	84 1.4×	40 0.8×	60 1.4×	30 0.7×	5	154

Countries citing papers authored by Seth J. Welsh

Since Specialization

Citations

This map shows the geographic impact of Seth J. Welsh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seth J. Welsh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seth J. Welsh more than expected).

Fields of papers citing papers by Seth J. Welsh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seth J. Welsh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seth J. Welsh. The network helps show where Seth J. Welsh may publish in the future.

Co-authorship network of co-authors of Seth J. Welsh

This figure shows the co-authorship network connecting the top 25 collaborators of Seth J. Welsh. A scholar is included among the top collaborators of Seth J. Welsh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seth J. Welsh. Seth J. Welsh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Welsh, Seth J., et al.. (2025). Integration of structural modeling and CADD scores improve variant classification for CFH SCRs 5-18. Immunobiology. 230(4). 152953–152953.

Zhu, Yuan Xiao, Laura A. Bruins, Cecília Bonolo de Campos, et al.. (2025). Exploring BCL2 regulation and upstream signaling transduction in venetoclax resistance in multiple myeloma: potential avenues for therapeutic intervention. Blood Cancer Journal. 15(1). 10–10. 3 indexed citations

Welsh, Seth J., Yuzhou Zhang, & Richard J. Smith. (2025). Acquired drivers of C3 glomerulopathy. Clinical Kidney Journal. 18(3). sfaf022–sfaf022. 1 indexed citations

Meermeier, Erin W., Seth J. Welsh, Meaghen E. Sharik, et al.. (2022). Abstract 5588: PD-1 blockade synergizes with IMiDs to enhance bispecific T cell engager immune responses to Vk*MYChCRBN multiple myeloma by preventing T cell exhaustion. Cancer Research. 82(12_Supplement). 5588–5588. 1 indexed citations

Meermeier, Erin W., Seth J. Welsh, Meaghen E. Sharik, et al.. (2021). Tumor Burden Limits Bispecific Antibody Efficacy through T-cell Exhaustion Averted by Concurrent Cytotoxic Therapy. Blood Cancer Discovery. 2(4). 354–369. 67 indexed citations

Welsh, Seth J., Daniel L. Riggs, Erin W. Meermeier, et al.. (2021). Disrupting Ectopic Super-Enhancers to Treat Multiple Myeloma. Blood. 138(Supplement 1). 1593–1593. 1 indexed citations

Chesi, Marta, Caleb K. Stein, Victoria M. Garbitt, et al.. (2020). Monosomic Loss of MIR15A/MIR16-1 Is a Driver of Multiple Myeloma Proliferation and Disease Progression. Blood Cancer Discovery. 1(1). 68–81. 20 indexed citations

Riggs, Daniel L., Victoria M. Garbitt, Niamh Keane, et al.. (2019). Abstract 3015: IMiDs and BET inhibitors target distinct pathways of MYC dysregulation by super-enhancers in multiple myeloma. Cancer Research. 79(13_Supplement). 3015–3015. 1 indexed citations

Welsh, Seth J., et al.. (2018). IL-27p28 Production by XCR1+ Dendritic Cells and Monocytes Effectively Predicts Adjuvant-Elicited CD8+ T Cell Responses. ImmunoHorizons. 2(1). 1–11. 25 indexed citations

10.

Welsh, Seth J., Michelle L. Churchman, Marco Togni, Charles G. Mullighan, & James Hagman. (2017). Deregulation of kinase signaling and lymphoid development in EBF1-PDGFRB ALL leukemogenesis. Leukemia. 32(1). 38–48. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact